Statins: Can we advocate them for primary prevention of heart disease?

Volume: 70, Issue: 3, Pages: 270 - 273
Published: Jul 1, 2014
Abstract
The discovery of cholesterol-lowering agents, namely HMG-CoA reductase inhibitors or statins, ushered in a series of large cholesterol reduction trials. The first of these studies was the Scandinavian Simvastatin Survival Study (4S) in which hypercholesterolemic men with CHD who were treated with simvastatin had a reduction in major coronary events of 44% and a reduction in total mortality of 30%. Many more secondary prevention trials followed...
Paper Details
Title
Statins: Can we advocate them for primary prevention of heart disease?
Published Date
Jul 1, 2014
Volume
70
Issue
3
Pages
270 - 273
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.